Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Dow
Healthtrust
Covington
Farmers Insurance
Boehringer Ingelheim
Colorcon
Moodys
Cantor Fitzgerald

Generated: October 24, 2017

DrugPatentWatch Database Preview

MILNACIPRAN HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Milnacipran Hydrochloride, and when can generic versions of Milnacipran Hydrochloride launch?

Milnacipran Hydrochloride is a drug marketed by Windlas Hlthcare and Amneal Pharms and is included in two NDAs.

The generic ingredient in MILNACIPRAN HYDROCHLORIDE is milnacipran hydrochloride. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the milnacipran hydrochloride profile page.

Summary for Tradename: MILNACIPRAN HYDROCHLORIDE

US Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list68
Clinical Trials: see list2,332
Patent Applications: see list247
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MILNACIPRAN HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Windlas Hlthcare
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205071-001Jan 27, 2016DISCNNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205081-003Apr 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Windlas Hlthcare
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205071-004Jan 27, 2016DISCNNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205081-004Apr 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Windlas Hlthcare
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205071-002Jan 27, 2016DISCNNoNo► Subscribe► Subscribe► Subscribe
Windlas Hlthcare
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205071-003Jan 27, 2016DISCNNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205081-002Apr 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
MILNACIPRAN HYDROCHLORIDE
milnacipran hydrochloride
TABLET;ORAL205081-001Apr 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cipla
Healthtrust
Chinese Patent Office
Fish and Richardson
McKinsey
Baxter
Express Scripts
Chubb
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot